COMMENTARY - COVID-19 in Nigeria: Implications for Management of Related Co-morbidities, Prevalent Public Health Challenges, and Future Epidemic Preparedness

Toyin Togun, Bolanle A. Ola, Esin Nkereuwem, Eniyou C. Oriero, Uduak Okomo, Mohammed O. Afolabi

Abstract

The Coronavirus Disease-2019 (COVID-19) pandemic is now well-established in Africa with cases reported from all countries on the continent. Despite the significant progress that has been made in the response to the pandemic in Nigeria, relative to the period of Ebola epidemic, the currently reported number of COVID-19 cases are likely under-estimates of the true number of cases. This is attributable to restricted testing capacity due to limited technical, infrastructural, financial, and logistical capacity to rapidly scale-up testing. In this article, we explore the impact of the COVID-19 pandemic on management of related co-morbidities and the major prevalent public health challenges, including mental health, in Nigeria, Africa’s most populous country. We also discuss the most current knowledge about candidate vaccines for the control of the novel coronavirus (SARS-CoV-2) strain. The interactions between COVID-19 and the endemic public health challenges in Nigeria further highlight the linkage between infectious diseases and poverty, and emphasise the need for a sustained increase in investments in the general public health system that is geared toward achieving Universal Health Coverage in Nigeria.

Keywords

Keywords: COVID-19; Nigeria; Comorbidity; Mental Health; Epidemic preparedness

Full Text:

PDF

References

Adeloye D, David R A, Olaogun A A, Auta A, Adesokan A, Gadanya M, Opele J K, Owagbemi O, Iseolorunkanmi A. Health workforce and governance: the crisis in Nigeria. Hum Resour Health 2017;15(1):32.

Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV 2020;7(5):e319-e20.

African Centre for Disease Control and Prevention. Corona Virus Disease 2019 (COVID-19) Dashboard. Addis Ababa, Ethiopia (2020). Available from: https://africacdc.org/covid-19/ (Cited 2 June 2020)2020.

Alagna R, Besozzi G, Codecasa L R, Gori A, Migliori G B, Raviglione M, Cirillo D M. Celebrating World Tuberculosis Day at the time of COVID-19. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2020;55(4).

Amimo F, Lambert B, Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Trop Med Health 2020;48:32.

Baldwin R, Tomiura E. Thinking ahead about the trade impact of COVID-19. (Chapter 5) 59-71.

Baldwin R, Mauro B W, editors. CEPR Press, London, UK (2020). Available from: https://cepr.org/sites/default/files/news/COVID-19.pdf (Cited 30 May 2020): CEPR Press, , 2020.

Barrett R, Brown P J. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. The Journal of infectious diseases 2008;197 Suppl 1:S34-S7.

Beigel J H, Tomashek K M, Dodd L E, Mehta A K, Zingman B S, Kalil A C, Hohmann E, Chu H Y, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg R W, Dierberg K, Tapson V, Hsieh L, Patterson T F, Paredes R, Sweeney D A, Short W R, Touloumi G, Lye D C, Ohmagari N, Oh M-d, Ruiz-Palacios G M, Benfield T, Fätkenheuer G, Kortepeter M G, Atmar R L, Creech C B, Lundgren J, Babiker A G, Pett S, Neaton J D, Burgess T H,

Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane H C. Remdesivir for the Treatment of Covid-19 — Preliminary Report. New England Journal of Medicine 2020.

Cascella M, Rajnik M, Cuomo A, Dulebohn S C, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. Treasure Island (FL); 2020.

Chen Q, Liang M, Li Y, Guo J, Fei D, Wang L, He L, Sheng C, Cai Y, Li X, Wang J, Zhang Z. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry 2020;7(4):e15-e6.

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, Smith L. Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review. Int J Environ Res Public Health 2020;17(8).

Djalante R, Shaw R, DeWit A. Building resilience against biological hazards and pandemics: COVID-19 and its implications for the Sendai Framework. Progress in Disaster Science 2020;6:100080.

Egere U, Togun T, Sillah A, Mendy F, Otu J, Hoelscher M, Heinrich N, Hill P C, Kampmann B. Identifying children with tuberculosis among household contacts in The Gambia. Int J Tuberc Lung Dis 2017;21(1):46-52.

Erunke J. FG to convert tuberculosis testing machines to COVID-19's - Minister; 2020. Available from: https://www.vanguardngr.com/2020/03/fg-to-convert-tuberculosis-testing-machines-to-covid-19s-%E2%80%95-minister/. [Accessed 5 June 2020].

Eshraghi A A, Li C, Alessandri M, Messinger D S, Eshraghi R S, Mittal R, Armstrong F D. COVID-19: overcoming the challenges faced by individuals with autism and their families. Lancet Psychiatry 2020;7(6):481-3.

Frasquilho D, Matos M G, Salonna F, Guerreiro D, Storti C C, Gaspar T, Caldas-de-Almeida J M. Mental health outcomes in times of economic recession: a systematic literature review. BMC public health 2016;16:115.

Gouda H N, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari A J, Erskine H, Leung J, Santamauro D, Lund C, Aminde L N, Mayosi B M, Kengne A P, Harris M, Achoki T, Wiysonge C S, Stein D J, Whiteford H. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. The Lancet Global health 2019;7(10):e1375-e87.

Graham W J, Afolabi B, Benova L, Campbell O M, Filippi V, Nakimuli A, Penn-Kekana L, Sharma G, Okomo U, Valongueiro S, Waiswa P, Ronsmans C. Protecting hard-won gains for mothers and newborns in low-income and middle-income countries in the face of COVID-19: call for a service safety net. BMJ Glob Health 2020a;5:e002754.

Graham W J, Afolabi B, Benova L, Campbell O M R, Filippi V, Nakimuli A, Penn-Kekana L, Sharma G, Okomo U, Valongueiro S, Waiswa P, Ronsmans C. Protecting hard-won gains for mothers and newborns in low-income and middle-income countries in the face of COVID-19: call for a service safety net. BMJ Glob Health 2020b;5(6).

Greer B, Robotham D, Simblett S, Curtis H, Griffiths H, Wykes T. Digital Exclusion Among Mental Health Service Users: Qualitative Investigation. J Med Internet Res 2019;21(1):e11696.

Guan W J, Ni Z Y, Hu Y, Liang W H, Ou C Q, He J X, Liu L, Shan H, Lei C L, Hui D S C, Du B, Li L J, Zeng G, Yuen K Y, Chen R C, Tang C L, Wang T, Chen P Y, Xiang J, Li S Y, Wang J L, Liang Z J, Peng Y X, Wei L, Liu Y, Hu Y H, Peng P, Wang J M, Liu J Y, Chen Z, Li G, Zheng Z J, Qiu S Q, Luo J, Ye C J, Zhu S Y, Zhong N S. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine 2020;382(18):1708-20.

Hassan S A, Sheikh F N, Jamal S, Ezeh J K, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus 2020;12(3):e7355.

Health Research Authority. A phase I/II study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers.

National Health Services (NHS), United Kingdom. Available from https://www.hra.nhs.uk/covid-19-research/approved-covid-19-research/281259/. Accessed 29 May 20202020.

Holmes E A, O'Connor R C, Perry V H, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski A K, Shafran R, Sweeney A, Worthman C M, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 2020;7(6):547-60.

Hotez P J, Nuzhath T, Colwell B. Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Current opinion in virology 2020;41:1-7.

Hussain A, Bhowmik B, do Vale Moreira N C. COVID-19 and diabetes: Knowledge in progress. Diabetes research and clinical practice 2020;162:108142.

Jia Y, Shen G, Zhang Y, Huang K-S, Ho H-Y, Hor W-S, Yang C-H, Li C, Wang W-L. Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity. bioRxiv 2020:2020.04.09.034942.

Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020;12(4).

Jones R, Nelson M, Bracchi M, Asboe D, Boffito M. COVID-19 in patients with HIV. Lancet HIV 2020;7(6):e383.

Kar S K, Yasir Arafat S M, Kabir R, Sharma P, Saxena S K. Coping with Mental Health Challenges During COVID-19. In: Saxena S K, editor. Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Singapore: Springer Singapore; 2020. p. 199-213.

Kavanagh M M, Erondu N A, Tomori O, Dzau V J, Okiro E A, Maleche A, Aniebo I C, Rugege U, Holmes C B, Gostin L O. Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics. Lancet 2020;395(10238):1735-8.

Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Health 2020;4(6):421.

M Afolabi B, Olukosi A. Malaria and anemia among pregnant women living in communities along the coast of Lagos Lagoon, South-west Nigeria. International Journal of Pregnancy & Child Birth 2018;4(6).

Mbow M, Lell B, Jochems S P, Cisse B, Mboup S, Dewals B G, Jaye A, Dieye A, Yazdanbakhsh M. COVID-19 in Africa: Dampening the storm? Science 2020;369(6504):624-6.

Mhango M, Chitungo I, Dzinamarira T. COVID-19 Lockdowns: Impact on Facility-Based HIV Testing and the Case for the Scaling Up of Home-Based Testing Services in Sub-Saharan Africa. AIDS and behavior 2020:1-3.

Motta I, Centis R, D'Ambrosio L, García-García J M, Goletti D, Gualano G, Lipani F, Palmieri F, Sánchez-Montalvá A, Pontali E, Sotgiu G, Spanevello A, Stochino C, Tabernero E, Tadolini M, van den Boom M, Villa S, Visca D, Migliori GB. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020.

National Institutes of Health. Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV). Available from: https://www.clinicaltrials.gov/ct2/show/NCT04456595. (cited 27 August 2020)2020a.

National Institutes of Health. Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),,. Available from: NIH. https://clinicaltrials.gov/ct2/show/NCT04283461. (cited 27 August 2020)2020b.

Nigeria Centre for Disease Control. COVID-19 Nigeria. Abuja, Nigeria. (2020). Available from: https://covid19.ncdc.gov.ng (Cited 7 June 2020)2020.

Njenga M K, Dawa J, Nanyingi M, Gachohi J, Ngere I, Letko M, Otieno C F, Gunn B M, Osoro E. Why is There Low Morbidity and Mortality of COVID-19 in Africa? The American journal of tropical medicine and hygiene 2020.

O'Reilly K M, Auzenbergs M, Jafari Y, Liu Y, Flasche S, Lowe R. Effective transmission across the globe: the role of climate in COVID-19 mitigation strategies. Lancet Planet Health 2020;4(5):e172.

Oladeinde B H, Omoregie R, Olley M, Anunibe J A, Onifade A A, Oladeinde O B. Malaria and Anemia among Children in a Low Resource Setting In Nigeria. Iran J Parasitol 2012;7(3):31-7.

Oladele T T, Olakunde B O, Oladele E A, Ogbuoji O, Yamey G. The impact of COVID-19 on HIV financing in Nigeria: a call for proactive measures. BMJ Glob Health 2020;5(5).

Our World in Data. World map: total tests performed relative to the size of population. Available from: https://ourworldindata.org/coronavirus-testing#world-map-total-tests-performed-relative-to-the-size-of-population (cited August 27 2020)2020.

Pang Y, Liu Y, Du J, Gao J, Li L. Impact of COVID-19 on tuberculosis control in China. Int J Tuberc Lung Dis 2020;24(5):545-7.

Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò F E. COVID-19 diagnosis and management: a comprehensive review. Journal of internal medicine 2020.

Pinto R M, Park S. COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers. AIDS and behavior 2020:1-4.

Poland G A. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Vaccine 2020;38(27):4219-20.

President’s Malaria Initiative N. Nigeria - Malaria Operational Plan FY 2019. 2019:79.

Roberton T, Carter E D, Chou V B, Stegmuller A R, Jackson B D, Tam Y, Sawadogo-Lewis T, Walker N. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health 2020.

Roberts L. Global polio eradication falters in the final stretch. Science 2020;367(6473):14-5.

Saunders M J, Evans C A. COVID-19, tuberculosis, and poverty: preventing a perfect storm. Eur Respir J 2020.

The Global Fund. Guidance notes on responding to COVID-19; 2020. Available from: https://www.theglobalfund.org/media/9397/core covid-19_guidancenote_en.pdf?u=637189162540000000. [Accessed 5 June 2020].

The Lancet. COVID-19 in Africa: no room for complacency - The Lancet. 2020.

Togun T, Kampmann B, Stoker N G, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob 2020;19(1):21.

U.S Food and Drug Administratin (FDA). Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. Silver Spring MD, USA. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment (Cited 2 June 2020).

UNAIDS. Nigeria; 2018. Available from: https://www.unaids.org/en/regionscountries/countries/nigeria. [Accessed 5 June 2020].

UNICEF. Global delivery care coverage and trends- UNICEF/WHO joint database on SDG 3.1.2 Skilled Attendance at Birth, February 2020 update. 2020.

United Nations. Transforming our world: the 2030 Agenda for Sustainable Development; 2015. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld. [Accessed 4 June 2020].

United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & Trends in Child Mortality: Report 2019, Estimates Developed by the UN Inter-agency Group for Child Mortality Estimation. In: Fund UNCs, editor. 2019.

Vizcarra P, Pérez-Elías M J, Quereda C, Moreno A, Vivancos M J, Dronda F, Casado J L. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020.

Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Journal of medical virology 2020.

WHO. World Malaria Report; 2019. Available from: https://www.who.int/malaria/publications/world-malaria-report-2019/en/. [Accessed 02/06/ 2020].

Wind T R, Rijkeboer M, Andersson G, Riper H. The COVID-19 pandemic: The 'black swan' for mental health care and a turning point for e-health. Internet Interv 2020;20:100317-.

World Health Organization. The End TB Strategy; 2015a. Available from: https://www.who.int/tb/strategy/end-tb/en/. [Accessed 5 June 2020].

World Health Organization. Global technical strategy for malaria, 2016-20302015b 2015.

World Health Organization. Guidelines for the treatment of malaria. Geneva: World Health Organization, 2015c 2015.

World Health Organization. Global tuberculosis report 2019; 2019a. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1. [Accessed 5 June 2020].

World Health Organization. Strategic Advisory Group of Experts on Immunization. The Global Vaccine Action Plan 2011-2020. Review and lessons learned. Geneva: World Health Organization; 2019b.

World Health Organization. Trends in maternal mortality 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019c.

World Health Organization. World Malaria Report; 2019d. Available from: https://www.who.int/malaria/publications/world-malaria-report-2019/en/. [Accessed 02/06/ 2020].

World Health Organization. COVID-19 pandemic expands reach in Africa. WHO Regional Office for Africa, Brazzaville, Republic du Congo (2020): Available from: https://www.afro.who.int/news/covid-19-pandemic-expands-reach-africa (cited 2 June 2020)2020a.

World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases. Geneva, Switzerland (2020). Available from: https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases (cited 2 June 2020)2020b.

World Health Organization. Rolling updates on coronavirus disease (COVID-19). . WHO, Geneva, Switzerland. (2020) Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. (Accessed 08 May 2020)2020c.

World Health Organization. Statement by the Measles & Rubella Initiative: American Red Cross, U.S. CDC, UNICEF, UN Foundation and WHO. Retrieved from https://www.who.int/immunization/diseases/measles/statement_missing_measles_vaccines_covid-19/en/. Accessed 30 May 2020. 2020d.

World Health Organization. WHO | Personal protective equipment for COVID-19; 2020e. Available from: http://www.who.int/medical_devices/priority/COVID_19_PPE/en/. [Accessed 02/06 2020].

World Health Organization. WHO DRAFT landscape of COVID-19 candidate vaccines – 25 August 2020. Retrieved from https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines. Accessed 27 August 2020. 2020f.

World Health Organization. Working for global equitable access to COVID-19 vaccines. https://www.who.int/initiatives/act-accelerator/covax. (cited 27 August 2020)2020g.

Wu Z, McGoogan J M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA : the journal of the American Medical Association 2020.

Xu Z, Zhang C, Wang F S. COVID-19 in people with HIV. Lancet HIV 2020.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62.

Zhu F-C, Li Y-H, Guan X-H, Hou L-H, Wang W-J, Li J-X, Wu S-P, Wang B-S, Wang Z, Wang L, Jia S-Y, Jiang H-D, Wang L, Jiang T, Hu Y, Gou J-B, Xu S-B, Xu J-J, Wang X-W, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet:1-10.

Refbacks

  • There are currently no refbacks.